10-Q: CEA Industries Reports Q1 2024 Results Amidst Market Challenges and Delisting Concerns
Quarterly Report
CEA Industries reported a significant decrease in revenue and an increased net loss for the first quarter of 2024, while also facing potential delisting from the Nasdaq.
Summary
- CEA Industries experienced a substantial decrease in revenue, dropping to $235,000 in Q1 2024 from $4,683,000 in Q1 2023, a 95% decrease.
- The company's gross profit margin declined from 18% in Q1 2023 to a gross loss margin of 66% in Q1 2024.
- Operating expenses decreased by 41% to $769,000, primarily due to cost-cutting measures.
- The net loss for Q1 2024 was $917,000, compared to a net loss of $431,000 in Q1 2023.
- The company's backlog increased to $535,000 as of March 31, 2024, up from $435,000 at the end of 2023.
- Cash and cash equivalents decreased to $11,599,000 as of March 31, 2024, from $12,508,000 at the end of 2023.
- The company is facing potential delisting from Nasdaq due to not meeting the minimum bid price requirement.
Sentiment
Score: 2
Explanation: The document indicates a very negative outlook due to significant revenue decline, increased losses, potential delisting from Nasdaq, and ongoing operational challenges. While there are some positive notes like cost-cutting and backlog increase, the overall financial health and future prospects appear highly uncertain.
Positives
- Operating expenses decreased by 41% due to cost-cutting measures.
- The company's backlog increased by 23% from the end of 2023.
- Net bookings increased by 119% compared to the previous quarter.
Negatives
- Revenue decreased by 95% year-over-year.
- The company experienced a significant shift from gross profit to a gross loss.
- The net loss increased by 113% year-over-year.
- Cash reserves decreased by $909,000 during the quarter.
- The company received a delisting notice from Nasdaq.
Risks
- The company faces significant uncertainty regarding the timing of revenue recognition on its remaining performance obligations.
- There is no certainty that the current backlog will result in actual revenues.
- The company is facing potential delisting from Nasdaq, which could negatively impact the price and trading of its shares.
- The company's ability to obtain new bookings and fulfill its current backlog is uncertain due to the current economic climate and cost-cutting measures.
- The company's customers face challenges in securing funding, obtaining licenses, and completing facility construction, which can delay revenue recognition.
- The company has material weaknesses in its internal control over financial reporting.
Future Outlook
The company is evaluating merger and acquisition opportunities and other alternatives for its future, including the possibility of dissolving the company and distributing cash assets after satisfying obligations. The company is also focused on cost-cutting measures and improving its financial organization.
Management Comments
- Management believes the lower bookings are due to the suppression of capital expenditures in the cannabis market environment as a result of the prolonged effects of pricing and inflationary pressure, in addition to a reduced sales effort by the Company.
- Management is committed to continuing to improve our financial organization including, without limitation, expanding our accounting staff and improving our systems and controls to reduce our reliance on the manual nature of our existing systems.
Industry Context
The CEA industry is facing challenges including high energy costs, water usage issues, evolving waste regulations, inflationary pressures, and labor shortages. The cannabis growing sector is also experiencing declining prices and evolving quality standards. The food-related crops sector is facing disruption from evolving market demand, competition, and reorganization, including bankruptcies and lack of growth capital.
Comparison to Industry Standards
- The company's 95% revenue decrease is significantly worse than industry averages, which have seen growth in some sectors but also challenges in others.
- The shift from a gross profit to a gross loss is a major concern, indicating significant operational inefficiencies compared to industry benchmarks.
- The company's backlog increase is a positive sign, but the uncertainty around revenue recognition is a major risk, especially compared to companies with more stable revenue streams.
- The company's cash burn rate is concerning, especially compared to companies that have achieved profitability or have more robust funding.
- The potential delisting from Nasdaq is a significant negative, as most public companies in the CEA space are actively working to maintain or improve their listing status.
Management Changes
| Role | Previous Person | New Person | Effective Date | Reason |
|---|---|---|---|---|
| Chief Financial Officer | Ian Patel | na | 2024-06-04 | Employment services ended |
Legal Proceedings
- Sweet Cut Grow, LLC and Green Ice, LLC filed a demand for arbitration against the company for breach of contract, breach of warranty, and unjust enrichment, seeking $1,049,280 in damages plus interest.
- The company has asserted a counterclaim and intends to defend itself vigorously.
Related Party Transactions
- The company has a manufacturer representative agreement with RSX Enterprises, in which director James R. Shipley has a significant ownership interest.
- The company has agreements with Lone Star Bioscience, Inc., where director Nicholas Etten is the Chief Executive Officer.
Stakeholder Impact
- Shareholders are at risk due to the potential delisting from Nasdaq and the company's poor financial performance.
- Employees may be affected by ongoing cost-cutting measures and potential restructuring.
- Customers may experience delays due to supply chain issues and the company's financial instability.
- Suppliers may face uncertainty regarding future orders and payments.
Next Steps
- The company will continue to evaluate merger and acquisition opportunities and other alternatives for its future.
- The company will continue to take actions to reduce costs.
- The company will be provided a hearing with Nasdaq's Listing Committee to present a plan to regain compliance.
- The company will need to formulate and adopt a plan of dissolution if the Board of Directors decides to implement such a plan.
Key Dates
| Date | Description |
|---|---|
| 2021-03-22 | The Board approved the 2021 Equity Incentive Plan. |
| 2021-07-22 | The 2021 Equity Incentive Plan was approved by the stockholders. |
| 2021-07-26 | Date related to the New Facility Lease. |
| 2021-07-28 | The company entered into an agreement to lease a new facility in Louisville, CO. |
| 2022-01-17 | The Board of Directors revised the compensation plan for directors. |
| 2022-02-15 | The company received approximately $21,711,000 in net proceeds from an equity offering. |
| 2022-10-13 | The company entered into an agreement with Lone Star Bioscience, Inc. for engineering design services. |
| 2022-12-20 | Another agreement for engineering services was signed with Lone Star Bioscience, Inc. |
| 2023-01-02 | The company issued an RSU grant to three of its independent directors. |
| 2023-01-03 | The company issued an RSU grant to each of its four independent directors. |
| 2023-03-01 | Date related to a change order with Lone Star Bioscience, Inc. |
| 2023-10-20 | Sweet Cut Grow, LLC and Green Ice, LLC filed a demand for arbitration against the company. |
| 2024-01-02 | The company issued an RSU grant to three of its independent directors. |
| 2024-03-31 | End of the quarterly period covered by this report. |
| 2024-04-09 | The company received a second delisting notice from Nasdaq. |
| 2024-04-16 | The company filed an appeal with Nasdaq's Listing Committee. |
| 2024-05-02 | The employment services of Mr. Ian Patel were ended. |
| 2024-05-14 | Date of the report. |
| 2024-06-04 | Effective date of contract termination for Mr. Ian Patel. |
Keywords
CEA Industries, Controlled Environment Agriculture, Financial Results, Quarterly Report, Revenue Decline, Net Loss, Backlog, Nasdaq Delisting, Cost Cutting, Operating Expenses
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.